Najat Khan, PhD
Chief Executive Officer & President | Member, Board of Directors
New York, New York, United States · 1 connectionNot on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
Najat Khan, Ph.D., is an accomplished biopharma leader at the forefront of driving bold innovation to bring transformative therapies to patients. Building on a track record of integrating science, AI/data science, and business leadership across both large pharma and emerging TechBio, she serves as CEO, President, and Board Member at Recursion, where she is advancing an AI-native approach to discovering, developing, and delivering novel medicines to address unmet patient needs. At Recursion, Dr. Khan has combined bold vision with disciplined leadership to advance value and impact. She has sharpened the company’s portfolio and optimized resource allocation across its pipeline and operations – prioritizing and progressing multiple first-in-class and best-in-class clinical programs in oncology, rare disease, neuroscience, and inflammation & immunology, both internally and with biopharma partners. Dr. Khan also helped lead Recursion’s M&A combination with Exscientia – the largest TechBio deal of 2024 – and has expanded the Recursion OS 2.0 platform into an end-to-end engine for drug discovery and development, spanning biology, chemistry, and ClinTech. She has helped build a world-class
Experience
Jul 2024 to Dec 2025
Apr 2022
Jan 2023
May 2020 to May 2024
May 2020 to Jun 2023
Dec 2019 to May 2020
Apr 2019 to Dec 2019
Sep 2008 to Jan 2009
Mar 2008 to Dec 2009
Jun 2006 to Aug 2009
Education
Ph.D., Organic Chemistry (with a computational chemistry focus)
AI / Machine Learning (MIT Computer Science & Artificial Intelligence Laboratory (CSAIL)
Bachelors, Computational Chemistry (Chemistry and Computer Science), Economics